Schulte Advised Wellington Management Company in Challenging Bristol-Myers Squibb Takeover of Celgene Corporation

Schulte advised Wellington Management Company in challenging the $74-billion takeover of global biopharmaceutical company Celgene Corporation by Bristol-Myers Squibb.

The Schulte team advising Wellington Management was led by Ele Klein, partner and co-chair of the firm’s global Shareholder Activism Group. The team also included special counsel Adriana Schwartz and associate David Rothenberg.